Clinical Trial Update: mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating modified FOLFIRINOX as adjuvant chemotherapy for pancreatic cancer in Chinese patients; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• mFOLFIRINOX

Snippet

Sponsor: Sun Yat-sen University | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING